Fulcrum Therapeutics, Inc. Investigation: Learn More Now Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (“Fulcrum Therapeutics” or the “Company”) (NASDAQ: FULC)…. Read MoreJoin Investigation
